General practitioner perceptions of treatment benefits and costs in patients with hyperlipidaemia.
This study explored general practitioner (GP) perceptions of use of treatments to manage hyperlipidaemia and their cost implications. GPs recognized different levels of coronary heart disease (CHD) risk, but were not always aware of which were major factors. Most were unfamiliar with published guide...
| Main Authors: | , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
1998
|
| _version_ | 1797093088465780736 |
|---|---|
| author | Hobbs, F Holmes, J Pugner, K |
| author_facet | Hobbs, F Holmes, J Pugner, K |
| author_sort | Hobbs, F |
| collection | OXFORD |
| description | This study explored general practitioner (GP) perceptions of use of treatments to manage hyperlipidaemia and their cost implications. GPs recognized different levels of coronary heart disease (CHD) risk, but were not always aware of which were major factors. Most were unfamiliar with published guidelines on managing hyperlipidaemia, and were likely to initiate drug therapies even in low-risk patients with mild hyperlipidaemia. Clearer advice is needed on whom to treat and on dietary intervention with high-fibre as well as low-fat diets. |
| first_indexed | 2024-03-07T03:55:18Z |
| format | Journal article |
| id | oxford-uuid:c2abdb53-79fd-40f0-88b9-0c1d2e3bd1f8 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T03:55:18Z |
| publishDate | 1998 |
| record_format | dspace |
| spelling | oxford-uuid:c2abdb53-79fd-40f0-88b9-0c1d2e3bd1f82022-03-27T06:10:40ZGeneral practitioner perceptions of treatment benefits and costs in patients with hyperlipidaemia.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:c2abdb53-79fd-40f0-88b9-0c1d2e3bd1f8EnglishSymplectic Elements at Oxford1998Hobbs, FHolmes, JPugner, KThis study explored general practitioner (GP) perceptions of use of treatments to manage hyperlipidaemia and their cost implications. GPs recognized different levels of coronary heart disease (CHD) risk, but were not always aware of which were major factors. Most were unfamiliar with published guidelines on managing hyperlipidaemia, and were likely to initiate drug therapies even in low-risk patients with mild hyperlipidaemia. Clearer advice is needed on whom to treat and on dietary intervention with high-fibre as well as low-fat diets. |
| spellingShingle | Hobbs, F Holmes, J Pugner, K General practitioner perceptions of treatment benefits and costs in patients with hyperlipidaemia. |
| title | General practitioner perceptions of treatment benefits and costs in patients with hyperlipidaemia. |
| title_full | General practitioner perceptions of treatment benefits and costs in patients with hyperlipidaemia. |
| title_fullStr | General practitioner perceptions of treatment benefits and costs in patients with hyperlipidaemia. |
| title_full_unstemmed | General practitioner perceptions of treatment benefits and costs in patients with hyperlipidaemia. |
| title_short | General practitioner perceptions of treatment benefits and costs in patients with hyperlipidaemia. |
| title_sort | general practitioner perceptions of treatment benefits and costs in patients with hyperlipidaemia |
| work_keys_str_mv | AT hobbsf generalpractitionerperceptionsoftreatmentbenefitsandcostsinpatientswithhyperlipidaemia AT holmesj generalpractitionerperceptionsoftreatmentbenefitsandcostsinpatientswithhyperlipidaemia AT pugnerk generalpractitionerperceptionsoftreatmentbenefitsandcostsinpatientswithhyperlipidaemia |